| Title |
Human Babesiosis in Europe: what clinicians need to know
|
|---|---|
| Published in |
Infection, October 2013
|
| DOI | 10.1007/s15010-013-0526-8 |
| Pubmed ID | |
| Authors |
A. Hildebrandt, J. S. Gray, K.-P. Hunfeld |
| Abstract |
Although best known as an animal disease, human babesiosis is attracting increasing attention as a worldwide emerging zoonosis. Humans are commonly infected by the bite of ixodid ticks. Rare ways of transmission are transplacental, perinatal and transfusion-associated. Infection of the human host can cause a very severe host-mediated pathology including fever, and hemolysis leading to anemia, hyperbilirubinuria, hemoglobinuria and possible organ failure. In recent years, apparently owing to increased medical awareness and better diagnostic methods, the number of reported cases in humans is rising steadily worldwide. Hitherto unknown zoonotic Babesia spp. are now being reported from geographic areas where babesiosis was not previously known to occur and the growing numbers of travelers and immunocompromised individuals suggest that the frequency of cases in Europe will also continue to rise. Our review is intended to provide clinicians with practical information on the clinical management of this rare, but potentially life-threatening zoonotic disease. It covers epidemiology, phylogeny, diagnostics and treatment of human babesiosis and the potential risk of transfusion-transmitted disease with a special focus on the European situation. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 5 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Practitioners (doctors, other healthcare professionals) | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Lithuania | 1 | <1% |
| France | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 138 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 13% |
| Student > Ph. D. Student | 18 | 13% |
| Student > Bachelor | 17 | 12% |
| Student > Master | 15 | 11% |
| Other | 8 | 6% |
| Other | 23 | 16% |
| Unknown | 41 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 32 | 23% |
| Medicine and Dentistry | 20 | 14% |
| Veterinary Science and Veterinary Medicine | 9 | 6% |
| Biochemistry, Genetics and Molecular Biology | 8 | 6% |
| Immunology and Microbiology | 5 | 4% |
| Other | 19 | 13% |
| Unknown | 48 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2022.
All research outputs
#6,287,168
of 24,746,716 outputs
Outputs from Infection
#365
of 1,536 outputs
Outputs of similar age
#52,507
of 215,878 outputs
Outputs of similar age from Infection
#4
of 11 outputs
Altmetric has tracked 24,746,716 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,536 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,878 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.